Clinical-stage biopharma developing non-viral precision genome engineered TCR T cell therapies for solid tumors.
Get notified the moment PACT Pharma files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.